Filing Details
Dyne Therapeutics, Inc. (NASDAQ:DYN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:DYN
Dyne Therapeutics, Inc. (DYN) Files Quarterly Report for Q0
Dyne Therapeutics, Inc. (NASDAQ:DYN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 05, 2026.
At publication ·
What changed
Dyne Therapeutics, Inc. (NASDAQ:DYN) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Dyne Therapeutics filed its Q0 2026 quarterly report (Form 10-Q) with the SEC on November 5, 2026.
- The healthcare company's stock trades at $18.54 with a market capitalization of $2.8 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Dyne Therapeutics, Inc.'s stock currently trades at $18.54 with a market capitalization of $2.8B.
The 10-Q provides Dyne Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Dyne Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DYN Stock Page
Frequently Asked Questions
Where can I read DYN's SEC filings?
Browse all filings on our DYN SEC filings page.
What types of SEC filings does Dyne Therapeutics, Inc. file?
Public companies like Dyne Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.